Myopic adopts the cost model for all of its non-current depreciable assets and because it is listed on the Australian Securities Exchange (ASX), it complies with AASB 116 Property, Plant and Equipment and AASB 136 Impairment of Assets. On 1 July 2019, Myopic Ltd purchased the plant at a cost of $3,336,000. The plant has an estimated useful life of 12 years, an estimated residual value of zero and will be depreciated using the straight-line method.

For the year ended 30 June 2020, an impairment loss of $89,000 was recognised in relation to the plant resulting in a carrying amount after accumulated impairment and depreciation of $2,969,000.

For the year ended 30 June 2021, there are indicators of impairment/reversal of impairment present and the recoverable amount of the plant is estimated to be $3,614,000.

Required:

Which of the following statements is NOT correct for the year ended 30 June 2021?

	A.	Myopic Ltd would recognise a revenue item Reversal of Impairment loss equal to $80,909.
	B.	The carrying amount of the plant after any depreciation and impairment adjustments in Myopic Ltds balance sheet is $2,780,000.
	C.	Myopic Ltd would recognise a revenue item Reversal of Impairment Loss equal to $914,909.
	D.	The carrying amount of the plant prior to any impairment/reversal of impairment in Myopic Ltds balance sheet is $2,699,091.